Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling methodology in physiopathology.

Jean-Pierre Boissel1, Benjamin Ribba, Emmanuel Grenier

  • 1CNRS, UMR5558, Lyon, France. jpb@upcl.univ-lyon1.fr

Progress in Biophysics and Molecular Biology
|January 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of inclisiran efficacy in patients with established atherosclerotic cardiovascular disease: the SIRIUS In-Silico modelling of cardiovascular outcomes.

European journal of preventive cardiology·2025
Same author

Credibility assessment of a mechanistic model of atherosclerosis to predict cardiovascular outcomes under lipid-lowering therapy.

NPJ digital medicine·2025
Same author

Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair.

Nature communications·2024
Same author

Multi-strain modeling of influenza vaccine effectiveness in older adults and its dependence on antigenic distance.

Scientific reports·2024
Same author

Sustained effect of prasinezumab on Parkinson's disease motor progression in the open-label extension of the PASADENA trial.

Nature medicine·2024
Same author

In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme.

European journal of preventive cardiology·2024
Same journal

Biological functions of BAF57, its role in disease pathogenesis, and treatment: From molecular mechanisms to clinical translation.

Progress in biophysics and molecular biology·2026
Same journal

Photonics-integrated and AI-enhanced medical sensing: From molecular diagnostics to real-time cell therapy monitoring.

Progress in biophysics and molecular biology·2026
Same journal

Uncovering the Biological Mechanisms of TREM2 with Molecular Simulations: A Comprehensive Review and Perspective.

Progress in biophysics and molecular biology·2026
Same journal

Advances in artificial joint testing driven by in situ mechanical characterization: From permeability of porous structures to dynamic wear monitoring.

Progress in biophysics and molecular biology·2026
Same journal

Proteostasis-driven redox adaptation in ferroptosis: the p62-Keap1-Nrf2 axis.

Progress in biophysics and molecular biology·2026
Same journal

NLRs and STANDs: a class of enthalpy and entropy dual-driven allosteric switches varying information entropies.

Progress in biophysics and molecular biology·2026
See all related articles

Developing accurate disease models requires a flexible methodology to handle complex systems. This approach addresses uncertainty from varying evidence levels and missing data for better model validation.

Area of Science:

  • Systems biology
  • Computational modeling
  • Physiopathology

Background:

  • Diseases represent complex, multidimensional systems requiring sophisticated modeling approaches.
  • Current disease modeling is time- and resource-intensive, necessitating optimized methodologies.
  • Existing models face challenges due to variability in data quality and missing parameters.

Purpose of the Study:

  • To propose a practical methodology for developing and validating complex disease models.
  • To address the inherent uncertainties in disease modeling, including data variability and missing information.
  • To outline a strategic and flexible approach for managing the intricate process of model development.

Main Methods:

  • Developing a flexible modeling strategy adaptable to diverse disease complexities.

Related Experiment Videos

  • Implementing guidance for model validation within the methodology.
  • Integrating techniques to manage parameter ranges, levels of evidence, and missing data.

    • Main Results:

    • A structured methodology for disease systems physiopathology modeling.
    • Strategies to mitigate uncertainty arising from data heterogeneity and incompleteness.
    • Improved approaches for optimizing the model development process.

    Conclusions:

    • A practical and strategic methodology is essential for effective disease modeling.
    • Addressing uncertainty is key to enhancing the validity and reliability of disease models.
    • Further development of tools is needed for integrating diverse data types in complex biological systems.